Michael P. Silvon
Direttore/Membro del Consiglio presso Chronic Airway Therapeutics
Provenienza dei contatti di primo grado di Michael P. Silvon
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics Pty Ltd. develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass.
3
| Private Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael P. Silvon tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Orphagenix, Inc. | Director/Board Member | ||
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree | |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Pharmaceuticals: Major | President | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| Aqumen Biopharmaceuticals NA, Inc. | President | ||
| Avatar Biotechnologies LLC | Director/Board Member | ||
| Joseph H Lauder Institute of Management & International | College/University | Graduate Degree | |
| INVION LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Accolade Pharma LLC is a pharmaceutical company that specializes in developing topical formulations and devices for the active ingredient of Accolate® (zafirlukast) to treat allergic inflammation. The private company is based in Wilmington, DE. Leukotriene antagonists modify allergic responses by blocking leukotrienes, which prevents or decreases symptoms of acute inflammation such as wheezing, sneezing, itching, redness, and swelling. The company was founded in 2012 by G. John Mohr, who has been the CEO since 2012. | Pharmaceuticals: Major | Chairman | |
KPMG Consulting Pte Ltd.
 KPMG Consulting Pte Ltd. Miscellaneous Commercial ServicesCommercial Services KPMG Consulting Pte Ltd. provides management consulting services. The private company is based in Singapore, Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
Polar Ventures Ltd.
 Polar Ventures Ltd. Financial ConglomeratesFinance Polar Ventures Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
| MYMD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kpmg Consulting Pty Ltd. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 15 |
| Australia | 5 |
| Giappone | 2 |
| Singapore | 2 |
Settori
| Health Technology | 9 |
| Consumer Services | 6 |
| Miscellaneous | 2 |
| Commercial Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 9 |
| Corporate Officer/Principal | 5 |
| Chairman | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| President | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Mitchell Glass | 15 |
| Thian Chew | 8 |
| Vinod Vijayakumar | 1 |
- Borsa valori
- Insiders
- Michael P. Silvon
- Connessioni Società
